Skip to main content

Abbvie To Buy Allergan For $60 Billion In Latest Pharma Megadeal

Abbvie will pay most of the price, represents a 45% premium over Allergan’s closing share price Monday of $129.57, in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.